Bioequivalence Study for Acarbose / Metformin FDC
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Bayer
Related studies linked through entity extraction aliases.
Open Label Study of BAY1082439 in Patients With Advanced Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Whole Brain Radiotherapy (WBRT) With Sorafenib for Breast Cancer Brain Metastases (BCBM)
- Status
- COMPLETED
- Phase
- PHASE1
First-in-man Dose Escalation Study of BAY2010112 in Patients With Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Rivaroxaban Laboratory Monitoring in Switzerland 2: Therapeutic Dose (RivaMoS 2)
- Status
- COMPLETED
- Phase
- N/A
Assessment of Strategies for the Management of Flu-like Symptoms in MS Patients Commencing Treatment With Betaferon (INFLUENCE)
- Status
- COMPLETED
- Phase
- N/A
Natalizumab De-escalation to Interferon-beta-1b in Patients With Relapsing-remitting Multiple Sclerosis
- Status
- TERMINATED
- Phase
- PHASE4
Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II)
- Status
- COMPLETED
- Phase
- N/A
Comparative Study of BAY86-5300 With an Extended Flexible Regimen for Endometriosis
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy/Safety Study to Explore a New Topical Formulation in Atopic Dermatitis
- Status
- WITHDRAWN
- Phase
- NA
Ciprofloxacin Special Drug Use Investigation - To Investigate the Safety and Efficacy in Patients With Ciprofloxacin iv Administration Without Dilution
- Status
- COMPLETED
- Phase
- N/A
Special Drug Use Investigation - Assessment of Efficacy and Safety in Treating Secondary Infection of Chronic Respiratory Disease
- Status
- COMPLETED
- Phase
- N/A
Regorafenib in Subjects With Gastrointestinal Stromal Tumors (GIST) Who Have Progressed After Standard Therapy (Managed Access Program)
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Dose Proportionality Study With BAY94-8862 IR (Immediate Release) Tablets
- Status
- COMPLETED
- Phase
- PHASE1
Special Drug Use Investigation of Glucobay OD
- Status
- COMPLETED
- Phase
- N/A
Oral Rivaroxaban in Children With Venous Thrombosis
- Status
- COMPLETED
- Phase
- PHASE2
Sorafenib and Topotecan in Refractory/Recurrent Pediatric Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Dose Escalation Study to Investigate Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of BAY85-3934 in Subjects With Chronic Kidney Disease (CKD)
- Status
- COMPLETED
- Phase
- PHASE1
Strategy of Continued Versus Interrupted Novel Oral Anti-coagulant at Time of Device Surgery in Patients With Moderate to High Risk of Arterial Thromboembolic Events
- Status
- COMPLETED
- Phase
- PHASE3
Explore the Efficacy and Safety of Once-daily Oral Rivaroxaban for the Prevention of Cardiovascular Events in Subjects With Nonvalvular Atrial Fibrillation Scheduled for Cardioversion
- Status
- COMPLETED
- Phase
- PHASE3